|
66 Companies |
|
64 Products |
|
64 Products |
|
38 Mechanisms of Action |
|
0 Trials |
|
1523 News |
|
| «12...1112131415161718192021...3031» |
- ||||| New P4 trial: Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration. (clinicaltrials.gov) - Feb 18, 2014
P4, N=1139, Completed, Sponsor: Green Cross Corporation
- paracetamol / Generic mfg.
Enrollment closed: Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV (clinicaltrials.gov) - Feb 16, 2014
P4, N=41, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting
- Trial completion: H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Feb 16, 2014
P1, N=105, Completed, Sponsor: Infectious Disease Research Institute
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||| Rebif (human IFN-β-1a) / EMD Serono
New P4 trial: RELIEF: A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis (clinicaltrials.gov) - Feb 13, 2014
P4, N=218, Not yet recruiting, Sponsor: Merck KGaA
- ||| Trial completion: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers (clinicaltrials.gov) - Feb 12, 2014
P1, N=272, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | New P4 trial: Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults (clinicaltrials.gov) - Feb 11, 2014
P4, N=2225, Completed, Sponsor: Jiangsu Province Centers for Disease Control and Prevention
- Trial termination: A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom (clinicaltrials.gov) - Feb 5, 2014
P=N/A, N=19, Terminated, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Completed --> Terminated; • Long delay due to challenges with sample analysis at local labs; • Low recruitment of case and control subjects; • Constant staff turn-over in the sites.
- ||||| Shingrix (zoster vaccine recombinant adjuvanted) / GSK, Japan Vaccine, Fluarix Quadrivalent (influenza vaccine) / GSK
Trial initiation date: Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older (clinicaltrials.gov) - Feb 5, 2014
P3, N=828, Active, not recruiting, Sponsor: GlaxoSmithKline
Completed --> Terminated; • Long delay due to challenges with sample analysis at local labs; • Low recruitment of case and control subjects; • Constant staff turn-over in the sites. Initiation date: Jan 2013 --> Oct 2013
- ||||| Enrollment closed, Preclinical: A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications (clinicaltrials.gov) - Feb 5, 2014
P3, N=430, Active, not recruiting, Sponsor: Novartis Vaccines
Initiation date: Jan 2013 --> Oct 2013 Recruiting --> Active, not recruiting
- ||||| Quinvaxem (diphtheria, Tetanus, whole-cell pertussis- HiB - HepB) / GSK
Enrollment closed: A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject (clinicaltrials.gov) - Feb 5, 2014
P3, N=400, Active, not recruiting, Sponsor: Crucell Holland BV
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Trial completion: Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal (clinicaltrials.gov) - Feb 5, 2014
P3, N=1761, Completed, Sponsor: Program for Appropriate Technology in Health
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| Trial completion: Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK (clinicaltrials.gov) - Feb 5, 2014
P=N/A, N=587, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2 (clinicaltrials.gov) - Feb 4, 2014
P1, N=333, Completed, Sponsor: Novavax
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1 (clinicaltrials.gov) - Feb 4, 2014
P1, N=333, Completed, Sponsor: Novavax
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu) (clinicaltrials.gov) - Feb 2, 2014
P2/3, N=240, Completed, Sponsor: Barts & The London NHS Trust
Active, not recruiting --> Completed Active, not recruiting --> Completed
- FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion: SNIF: Self-Administered Nasal Influenza Feasibility Study (clinicaltrials.gov) - Feb 2, 2014
P4, N=1100, Completed, Sponsor: Uniformed Services University of the Health Sciences
Active, not recruiting --> Completed Recruiting --> Completed
- busulfan / Generic mfg., decitabine / Generic mfg.
Trial completion, Combination therapy: PRO#0118: Decitabine Plus Mini Flu-Bu (clinicaltrials.gov) - Jan 31, 2014
P1, N=20, Completed, Sponsor: Hackensack University Medical Center
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed: Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) (clinicaltrials.gov) - Jan 30, 2014
P2, N=50, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Recruiting --> Active, not recruiting
- Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Enrollment change: Rituxivac: Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab (clinicaltrials.gov) - Jan 29, 2014
P=N/A, N=98, Completed, Sponsor: St. Antonius Hospital
Recruiting --> Active, not recruiting N=160 --> 98
- ||| FluLaval Quadrivalent (influenza vaccine) / GSK
Enrollment closed: Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age (clinicaltrials.gov) - Jan 29, 2014
P2, N=316, Active, not recruiting, Sponsor: GlaxoSmithKline
N=160 --> 98 Recruiting --> Active, not recruiting
- |||| Fluarix (influenza virus trivalent vaccine) / GSK
Trial completion: Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old (clinicaltrials.gov) - Jan 29, 2014
P4, N=131, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Trial completion: Rituxivac: Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab (clinicaltrials.gov) - Jan 29, 2014
P=N/A, N=98, Completed, Sponsor: St. Antonius Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza (clinicaltrials.gov) - Jan 27, 2014
P=N/A, N=178, Completed, Sponsor: University of Maryland
Recruiting --> Completed N=1000 --> 178
- FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Enrollment change: Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers (clinicaltrials.gov) - Jan 27, 2014
P=N/A, N=51, Completed, Sponsor: University of North Carolina, Chapel Hill
N=1000 --> 178 N=84 --> 51
- ||| Enrollment open: Residual Sample Collection for Respiratory Viral Panel (clinicaltrials.gov) - Jan 27, 2014
P=N/A, N=1500, Recruiting, Sponsor: GenMark Diagnostics
N=84 --> 51 Not yet recruiting --> Recruiting
- Trial completion: Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza (clinicaltrials.gov) - Jan 27, 2014
P=N/A, N=178, Completed, Sponsor: University of Maryland
Not yet recruiting --> Recruiting Recruiting --> Completed
- FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion: Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers (clinicaltrials.gov) - Jan 27, 2014
P=N/A, N=51, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Completed Recruiting --> Completed
- | favipiravir / Generic mfg.
Enrollment open: Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316 (clinicaltrials.gov) - Jan 27, 2014
P3, N=660, Recruiting, Sponsor: MDVI, LLC
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed: ICC H1: Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum (clinicaltrials.gov) - Jan 27, 2014
P1, N=12, Active, not recruiting, Sponsor: Vaxart
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | VIS410 / Otsuka
New P1 trial: A Study of VIS410 to Assess Safety and Pharmacokinetics (clinicaltrials.gov) - Jan 22, 2014
P1, N=30, Not yet recruiting, Sponsor: Visterra, Inc.
- |||| FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion: Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults (clinicaltrials.gov) - Jan 20, 2014
P4, N=300, Completed, Sponsor: MedImmune LLC
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || GSK3206641A / GSK, GSK3206640A / GSK
Enrollment closed: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age (clinicaltrials.gov) - Jan 15, 2014
P1, N=424, Active, not recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- H7N9 Anhui 2013/AA ca / National Institute of Allergy and Infectious Diseases
Enrollment closed: Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults (clinicaltrials.gov) - Jan 14, 2014
P1, N=48, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial completion: Evaluating Modes of Influenza Transmission (clinicaltrials.gov) - Jan 13, 2014
P=N/A, N=127, Completed, Sponsor: University of Nottingham
Recruiting --> Active, not recruiting Not yet recruiting --> Completed
- ||||| New P1/2 trial: Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old (clinicaltrials.gov) - Jan 12, 2014
P1/2, N=672, Recruiting, Sponsor: Novartis Vaccines
- ||||| Enrollment closed, Head-to-Head: Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older (clinicaltrials.gov) - Jan 8, 2014
P3, N=2680, Active, not recruiting, Sponsor: Novartis Vaccines
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Enrollment closed, Head-to-Head: Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old (clinicaltrials.gov) - Jan 8, 2014
P3, N=2349, Active, not recruiting, Sponsor: Novartis Vaccines
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||||| Shingrix (zoster vaccine recombinant adjuvanted) / GSK, Japan Vaccine, Fluarix Quadrivalent (influenza vaccine) / GSK
Enrollment closed: Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older (clinicaltrials.gov) - Jan 8, 2014
P3, N=828, Active, not recruiting, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||| Fluzone Quadrivalent (influenza vaccine) / Sanofi
Enrollment closed: Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine (clinicaltrials.gov) - Jan 8, 2014
P4, N=60, Active, not recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||| Trial completion: Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults (clinicaltrials.gov) - Jan 8, 2014
P1/2, N=80, Completed, Sponsor: AVIR Green Hills Biotechnology AG
Recruiting --> Active, not recruiting Recruiting --> Completed
- |||| Agriflu (trivalent influenza virus vaccine) / CSL Behring
Trial completion: Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above (clinicaltrials.gov) - Jan 8, 2014
P4, N=2902, Completed, Sponsor: Novartis
Recruiting --> Completed Recruiting --> Completed
- ||||||| Infanrix (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) / GSK, Rotarix (rotavirus vaccine) / GSK, Engerix-B (hepatitis B vaccine recombinant) / GSK
Trial completion: Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants (clinicaltrials.gov) - Jan 8, 2014
P3, N=4003, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Active, not recruiting --> Completed
- Fluzone (influenza vaccine) / Sanofi, Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
Trial completion: Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals (clinicaltrials.gov) - Jan 6, 2014
P4, N=232, Completed, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Influenza A 2009 H1N1 Challenge Study in Healthy Adults (clinicaltrials.gov) - Jan 2, 2014
P1/2, N=49, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed N=200 --> 49
- Trial completion: Influenza A 2009 H1N1 Challenge Study in Healthy Adults (clinicaltrials.gov) - Jan 2, 2014
P1/2, N=49, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=200 --> 49 Recruiting --> Completed
- ||||| Fluvirin (inactivated influenza virus vaccine) / CSL Behring
Enrollment closed, Preclinical: Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age (clinicaltrials.gov) - Jan 1, 2014
P3, N=2055, Active, not recruiting, Sponsor: Novartis Vaccines
Recruiting --> Completed Recruiting --> Active, not recruiting
- || favipiravir / Generic mfg.
New P3 trial: Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316 (clinicaltrials.gov) - Jan 1, 2014
P3, N=660, Recruiting, Sponsor: MDVI, LLC
- Trial completion: A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation (clinicaltrials.gov) - Dec 30, 2013
P2, N=148, Completed, Sponsor: Institut Paoli-Calmettes
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||||| favipiravir / Generic mfg.
Enrollment open, P3 data: Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults (clinicaltrials.gov) - Dec 29, 2013
P3, N=1056, Recruiting, Sponsor: MDVI, LLC
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| New P1 trial: Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. (clinicaltrials.gov) - Dec 25, 2013
P1, N=100, Not yet recruiting, Sponsor: Medicago